Skip to content

Relevance of Veinous Lactates to Predict Postoperative Complications in Children 0-1 Years

Relevance of Veinous Lactates Dosage at the End of a Surgical Procedure to Predict Postoperative Complications in Children 0-1 Years

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06909227
Acronym
PLANN
Enrollment
500
Registered
2025-04-03
Start date
2025-03-27
Completion date
2026-09-30
Last updated
2025-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General Anesthesia, Infant

Keywords

pediatric, anesthesia, lactate, complications

Brief summary

This study will investigate if the dosage of veinous lactate at the end of a surgical procedure is related to post-operative complications occurring within 3 months in young infants aged 0-1 years. Blood samples are acquired routinely before emergence of general anesthesia, from the IV line put in place for anesthesia. The investigators hypothesized that elevated lactates would be associated with more postoperative complications in this population, as is the case in adults.

Interventions

PROCEDUREsurgery under general anesthesia

Only in children, \< 1 year old non-cardiac surgery

Sponsors

Hôpital Armand Trousseau
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Years to 1 Years
Healthy volunteers
No

Inclusion criteria

* surgery under general anesthesia * age \< 1 year

Exclusion criteria

* ambulatory surgery * cardiac surgery * preoperative hemodynamic instability * Weight \< 2 kg

Design outcomes

Primary

MeasureTime frameDescription
Post-operative complications occurring within 3 months after surgerywithin 3 months after surgeryICU admission Re-operation Re-admission Death

Countries

France

Contacts

Primary ContactMireille Nasr, MD
mireille.nasr@aphp.fr+33667601819
Backup ContactNada Sabourdin, MD, PhD
nada.sabourdin@aphp.fr+33667185789

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026